A company called Moelis had some people who work there sell their shares, which are pieces of the company. Another company named DexCom also had someone sell their shares after they did well in a report. The article talks about these insiders selling their stocks and why it might be important for investors to know about it. Read from source...

1. The title is misleading and sensationalist. It implies that insiders are selling these stocks because they have negative information or expectations about them, which may not be true. Insiders may sell for various reasons unrelated to the company's performance or outlook, such as diversifying their portfolio, tax planning, personal needs, etc.
2. The article does not provide any context or data on how much insider selling is happening compared to other types of trading activity, such as buying by institutions, retail investors, or company executives. This makes it hard for readers to judge the significance and implications of the reported selling.
3. The article does not explain why Moelis posted a narrower-than-expected quarterly loss, which could be seen as a positive sign of its financial health and prospects. It also does not mention any other factors that may have influenced the insider's decision to sell, such as changes in the company's strategy, leadership, or market position.
4. The article only briefly mentions DexCom's upbeat quarterly earnings, but does not elaborate on the details or the reasons behind them. It also does not provide any analysis or commentary on how this performance may affect the stock's valuation, growth potential, or competitive advantage.
5. The article ends with a promotion for Benzinga's premium services and products, which seems to be irrelevant and unprofessional in the context of an informative and objective report on insider trading activity. It also creates a potential conflict of interest between the publisher and its readers, as it may encourage them to sign up for paid subscriptions based on fear or curiosity induced by the sensationalist title.

Neutral
Explanation: The article discusses insider selling of stocks in Moelis and DexCom. It also mentions the quarterly results of Moelis and DexCom. However, it does not provide a clear indication of whether these developments are bullish or bearish for the respective companies or the market as a whole. Therefore, the sentiment is neutral.